Study at a glance
What did studies compare about vitamin D, thinking skills and dementia?
This page compares studies of vitamin D blood levels and later dementia or changes in thinking skills with trials of vitamin D3 supplements. Observing a link between a low blood level and later illness is different from showing that treatment prevents the illness. The studies also measured different outcomes, including new dementia diagnoses and performance on memory and planning tests.
Were low vitamin D levels linked with dementia or declining thinking skills?
A study of 1,658 older adults initially without dementia found a higher rate of later dementia in people with lower vitamin D. Another study found faster decline in memory and planning skills in lower-vitamin-D groups, but not in every area tested. These findings could partly reflect other health and lifestyle differences. Early disease may also change diet or outdoor activity before diagnosis, lowering vitamin D.
Did vitamin D supplements slow declining thinking skills?
A trial called VITAL did not show an overall slowing of decline in thinking skills with vitamin D3 over about two to three years. Its two assessment groups came from one trial, not two independent trials. A favourable subgroup finding needed confirmation. Another trial, called VitaMIND, also reported no significant overall benefit for thinking skills over two years. People qualified for the study as having low vitamin D based on a questionnaire, with blood confirmation available only for a small subgroup.
What remains uncertain about vitamin D and dementia prevention?
Missing later assessments and limited evidence in people with severe deficiency restrict how widely the trial findings apply. Possible biological explanations were not proven by these human studies. Low vitamin D may be a useful sign of risk to investigate, but these results do not establish a blood target, supplement dose or proven way to prevent dementia.
Read the full article below ↓Lower blood vitamin D has been associated with later dementia and faster decline in some cognitive abilities. Those associations do not establish that supplements prevent either outcome. Randomised trials provide an important check on that interpretation. For the detailed evidence and limitations, read Vitamin D Status, Cognitive Decline and Dementia Associations: Full Study.
What the observational studies found
Littlejohns and colleagues followed 1,658 older adults who initially had no dementia, stroke or cardiovascular disease. Lower baseline vitamin D categories were associated with a higher rate of later dementia. The lowest category had a fully adjusted hazard ratio of 2.25 compared with the highest category, with a wide confidence interval. This relative rate is not an individual probability or an expected treatment benefit.
Miller and colleagues followed a multiethnic cohort with repeated cognitive tests. Lower vitamin D categories were associated with faster decline in episodic memory, the ability to recall experiences, and executive function, which supports planning and switching tasks, but not every measured domain. The population included people with differing cognitive status at entry. The studies therefore address related but distinct questions within the brain evidence.
Why association does not establish prevention
Low vitamin D can accompany changes in health, diet and outdoor activity. Early disease may influence these factors before a diagnosis is recorded. Statistical adjustment and exclusion of early diagnoses help, but cannot remove every source of confounding or reverse causation. The cohorts also used different vitamin D categories and cognitive outcomes.
What supplementation trials add
The VITAL cognitive study tested 2,000 international units of vitamin D3 daily against placebo in two subsets of one parent trial. It did not demonstrate an overall slowing of cognitive decline over approximately two to three years. A favourable subgroup finding required cautious interpretation and replication. The two subsets are not two independent trials.
The 2025 VitaMIND trial likewise reported no significant overall cognitive benefit over twenty-four months. Its low-status eligibility was predicted by questionnaire; blood confirmation was available only in a small subgroup. Substantial missing follow-up data and limited representation of severe deficiency restrict generalisation. The tested doses do not become recommendations for readers.
What remains uncertain
The neighbouring concepts of neuroendocrine integration and inflammatory signalling provide possible biological explanations, but these human studies did not prove those mechanisms. A plausible pathway cannot substitute for a demonstrated clinical effect.
The evidence supports studying low vitamin D as a risk marker. It does not establish a blood target, supplement dose or proven method of preventing dementia. Better evidence requires clearly defined populations, confirmed exposure, sustained follow-up and meaningful cognitive outcomes. Unavailable supplementary cohort and prediction-model material was not treated as independently verified.
Scientific sources
Littlejohns TJ, Henley WE, Lang IA, et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology. 2014;83:920 to 928. DOI:10.1212/WNL.0000000000000755. PMID:25098535. Complete principal paper, two figures and three tables examined; supplementary tables were inaccessible.
Miller JW, Harvey DJ, Beckett LA, et al. Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. JAMA Neurology. 2015;72:1295 to 1303. DOI:10.1001/jamaneurol.2015.2115. PMID:26366714. Complete principal paper, trajectory figure and four tables examined; supplemental table was inaccessible.
Kang JH, Vyas CM, Okereke OI, et al. Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial. Scientific Reports. 2021;11:23253. DOI:10.1038/s41598-021-02485-8. PMID:34853363. Complete principal paper, main figure, six tables and eight-page supplementary appendix examined. A validation plot cited in the appendix was not present in the retrieved file.
Corbett A, Taylor R, Llewellyn D, et al. Impact of Vitamin D Supplementation on Cognition in Adults With Mild to Moderate Vitamin D Deficiency: Outcomes From the VitaMIND Randomized Controlled Trial. Journal of the American Medical Directors Association. 2025;26:105711. DOI:10.1016/j.jamda.2025.105711. PMID:40480279. Complete principal-report text and tabulated outcomes read; supplementary prediction material was inaccessible. Used as bounded supporting evidence.
Related reading
The Influence of Vitamin D Status on Cognitive Ability in Patients with Bipolar Disorder and Healthy Controls
Thus, we aimed to investigate the association between 25-hydroxyvitamin D (25(OH)D), 24,25 dihydroxyvitamin D (24,25(OH)2D, the vitamin D metabolite ratio (VMR) and cognition in a cohort of euthymic patients with bipolar disorder.
Original paper ↗Read more →Vitamin D Deficiency in Institutionalized Older Adults: Associations with Supplementation Practices but Not with Cognitive Decline or Dementia
Background/Objectives: Population aging has been accompanied by increased institutionalization of older adults and a high prevalence of vitamin D deficiency in this group.
Original paper ↗Read more →Vitamin D Status, Cognitive Decline and Dementia Associations: Full Study
Assess associations of vitamin D status with memory, executive decline and dementia, alongside trial findings and the limits of causal interpretation.
Read more →Supplementation and Mitigating Cognitive Decline in Older Adults With or Without Mild Cognitive Impairment or Dementia: A Systematic Review
Results have shown that supplementation with vitamin D, probiotics, and PUFAs would most likely reduce cognitive decline, dementia, or AD compared with vitamins A, B, C, and E, which were seen to be relatively ineffective.
Original paper ↗Read more →Mental Health and Kidneys: The Interplay Between Cognitive Decline, Depression, and Kidney Dysfunction in Hospitalized Older Adults
This study aimed to investigate the associations among cognitive impairment, depression, and kidney involvement in elderly patients.
Original paper ↗Read more →Current Evidence on the Association of Micronutrient Malnutrition with Mild Cognitive Impairment, Frailty, and Cognitive Frailty among Older Adults: A Scoping Review
The purpose of this scoping review was to map current evidence on the association between micronutrient deficiency in blood and mild cognitive impairment, frailty, and cognitive frailty among older adults.
Original paper ↗Read more →Dietary vitamin D intake and 2-year changes in cognitive function in older adults with overweight or obesity and metabolic syndrome
We aimed to evaluate the association between dietary vitamin D intake and 2-year cognitive changes in older adults at risk of cognitive decline.
Original paper ↗Read more →Diversity and inclusivity in Australian dementia prevention research: A mixed methods review
Using co‐creation methodologies, the workshop aimed to generate consensus‐based recommendations for governments, institutions, and individual researchers to improve inclusivity and representativeness in future dementia prevention research.
Original paper ↗Read more →Factors associated with cognitive function outcomes among older adults in Kuwait: A cross-sectional study
A normal MMSE score was reported for 51.0% (n = 129) of the sample, with 34.7% and 14.2% of participants having mild and moderate/severe cognitive impairment, respectively.
Original paper ↗Read more →Interaction between ω-6 fatty acids intake and blood cadmium on the risk of low cognitive performance in older adults from National Health and Nutrition Examination Survey (NHANES) 2011 to 2014
This study evaluated the interaction effect between blood cadmium and ω-6 fatty acids intake on low cognitive performance in Americans.
Original paper ↗Read more →Association of dietary and nutritional factors with cognitive decline, dementia, and depressive symptomatology in older individuals according to a neurogenesis-centred biological susceptibility to brain ageing
Hippocampal neurogenesis (HN) occurs throughout the life course and is important for memory and mood.
Original paper ↗Read more →Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia
Participants were 178 dementia-free individuals aged 70 years or older with data on plasma 25(OH)D and cerebral Aβ load assessed by [18F]-florbetapir positron emission tomography.
Original paper ↗Read more →Investigating Modifiable Factors Associated with Cognitive Decline: Insights from the UK Biobank
After excluding participants with dementia and substantial missing data, 453,950 individuals from UK Biobank (UKB) were included.
Original paper ↗Read more →ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline
Objective: In the case of AD, there is not a single therapeutic that exerts anything beyond a marginal, unsustained, symptomatic effect.
Original paper ↗Read more →Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study
Studies investigating the association between 25-hydroxyvitamin D [25(OH)D] and cognition in the very old (85+) are lacking.
Original paper ↗Read more →Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden
In this study, we investigated the possible mechanisms involved in the neuroprotective effects of vitamin D on age-related brain changes and cognitive function.
Original paper ↗Read more →Association Between Physical Performance and Cognitive Function in Older Adults Across Multiple Studies: A Pooled Analysis Study
While several studies have examined the association between cognitive and physical function, the consistency of these associations across functional contexts is unclear.
Original paper ↗Read more →Nutritional intervention targeting muscle-brain axis in dementia continuum: from mechanisms to practice
Despite being the central pathophysiological substrate across these geriatric syndromes, skeletal muscle loss is still insufficiently prioritized as a treatment objective.
Original paper ↗Read more →Serum Vitamin D3 Concentration, Sleep, and Cognitive Impairment among Older Adults in China
Background: Cognitive decline in older adults has become one of the critical challenges to global health.
Original paper ↗Read more →Study of Diet Habits and Cognitive Function in the Chinese Middle-Aged and Elderly Population: The Association between Folic Acid, B Vitamins, Vitamin D, Coenzyme Q10 Supplementation and Cognitive Ability
The objective of the present cross-sectional study was to evaluate the relationship between cognitive ability and folic acid, B vitamins, vitamin D (VD) and Coenzyme Q10 (CoQ10) supplementation.
Original paper ↗Read more →Vitamin D Concentration and Motoric Cognitive Risk in Older Adults: Results from the Gait and Alzheimer Interactions Tracking (GAIT) Cohort
The objective of this cross-sectional analysis was to determine whether hypovitaminosis D was associated with MCR.
Original paper ↗Read more →Original sources
Vitamin D and the risk of dementia and Alzheimer disease
Published in Neurology (2014).
Publication details
Littlejohns TJ, Henley WE, Lang IA, et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology. 2014;83:920 to 928. DOI:10.1212/WNL.0000000000000755. PMID:25098535. Complete principal paper, two figures and three tables examined; supplementary tables were inaccessible.
Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults
Published in JAMA Neurology (2015).
Publication details
Miller JW, Harvey DJ, Beckett LA, et al. Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. JAMA Neurology. 2015;72:1295 to 1303. DOI:10.1001/jamaneurol.2015.2115. PMID:26366714. Complete principal paper, trajectory figure and four tables examined; supplemental table was inaccessible.
Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial
Published in Scientific Reports (2021).
Publication details
Kang JH, Vyas CM, Okereke OI, et al. Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial. Scientific Reports. 2021;11:23253. DOI:10.1038/s41598-021-02485-8. PMID:34853363. Complete principal paper, main figure, six tables and eight-page supplementary appendix examined. A validation plot cited in the appendix was not present in the retrieved file.
Impact of Vitamin D Supplementation on Cognition in Adults With Mild to Moderate Vitamin D Deficiency: Outcomes From the VitaMIND Randomized Controlled Trial
Published in Journal of the American Medical Directors Association (2025).
Publication details
Corbett A, Taylor R, Llewellyn D, et al. Impact of Vitamin D Supplementation on Cognition in Adults With Mild to Moderate Vitamin D Deficiency: Outcomes From the VitaMIND Randomized Controlled Trial. Journal of the American Medical Directors Association. 2025;26:105711. DOI:10.1016/j.jamda.2025.105711. PMID:40480279. Complete principal-report text and tabulated outcomes read; supplementary prediction material was inaccessible. Used as bounded supporting evidence.